Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Vicki A. Morrison

Treatment Approaches for Older and Oldest Patients With Diffuse Large B-Cell Lymphoma – Use of Non-R-Chop Alternative Therapies and Impact of Comorbidities on Treatment Choices and Outcome: A Humedica Database Retrospective Cohort Analysis, 2007–2015

Journal of Geriatric Oncology

English

Therapy With Bortezomib Plus Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma: Final Results of a Phase II Trial (CALGB 50501)

Leukemia and Lymphoma

English

Related publications

Impact of Comorbidities on Outcomes of Elderly Patients With Diffuse Large B-Cell Lymphoma

American Journal of Hematology

Hematology

2017

English

3A Comparison Between R-THP-Cop and R-Chop Regimens for the Treatment of Diffuse Large B-Cell Lymphoma in Old Patients: A Single-Institution Analysis

Internal Medicine

Medicine

2017

English

Biomarkers of Diffuse Large B-Cell Lymphoma: Impact on Diagnosis, Treatment, and Prognosis

Current Biomarker Findings

Biochemistry

Clinical Biochemistry

2013

English

Emerging Therapies for the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma

Current Oncology

Oncology

2019

English

Diffuse Large B-Cell Lymphoma Presenting With Gastrocolic Fistula and Successfully Treated With R-Chop Chemotherapy

Tenri Medical Bulletin

2018

English

Real-World Prognostic Impact of Bcl2 and Myc Expression and Translocation Among Diffuse Large B-Cell Lymphoma Patients Treated With First-Line R-Chop

Hematological Oncology

English

Diffuse Large B-Cell Lymphoma With Primary Treatment Failure: Ultra-High Risk Features and Benchmarking for Experimental Therapies

American Journal of Hematology

Hematology

2017

English

CD30 Expression in Diffuse Large B-Cell Lymphoma Correlates With Non-GCB Subtype but Does Not Have Prognostic Impact in Patients Treated With First Line R-Chop/R-Chop-Like

Hematological Oncology

English

Response of Diffuse Large B-Cell Lymphoma Treated With R-Chop and Prognostic Factors Associated: A Single Institution Analysis in Lima, Peru

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Vicki A. Morrison

Treatment Approaches for Older and Oldest Patients With Diffuse Large B-Cell Lymphoma – Use of Non-R-Chop Alternative Therapies and Impact of Comorbidities on Treatment Choices and Outcome: A Humedica Database Retrospective Cohort Analysis, 2007–2015

Therapy With Bortezomib Plus Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma: Final Results of a Phase II Trial (CALGB 50501)

Related publications

Impact of Comorbidities on Outcomes of Elderly Patients With Diffuse Large B-Cell Lymphoma

3A Comparison Between R-THP-Cop and R-Chop Regimens for the Treatment of Diffuse Large B-Cell Lymphoma in Old Patients: A Single-Institution Analysis

Biomarkers of Diffuse Large B-Cell Lymphoma: Impact on Diagnosis, Treatment, and Prognosis

Emerging Therapies for the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma

Diffuse Large B-Cell Lymphoma Presenting With Gastrocolic Fistula and Successfully Treated With R-Chop Chemotherapy

Real-World Prognostic Impact of Bcl2 and Myc Expression and Translocation Among Diffuse Large B-Cell Lymphoma Patients Treated With First-Line R-Chop

Diffuse Large B-Cell Lymphoma With Primary Treatment Failure: Ultra-High Risk Features and Benchmarking for Experimental Therapies

CD30 Expression in Diffuse Large B-Cell Lymphoma Correlates With Non-GCB Subtype but Does Not Have Prognostic Impact in Patients Treated With First Line R-Chop/R-Chop-Like

Response of Diffuse Large B-Cell Lymphoma Treated With R-Chop and Prognostic Factors Associated: A Single Institution Analysis in Lima, Peru